Amedisys Inc
NASDAQ:AMED
Amedisys Inc
Long-Term Investments
Amedisys Inc
Long-Term Investments Peer Comparison
Competitive Long-Term Investments Analysis
Latest Figures & CAGR of Competitors
Company | Long-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Amedisys Inc
NASDAQ:AMED
|
Long-Term Investments
$67m
|
CAGR 3-Years
69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Long-Term Investments
$540.3m
|
CAGR 3-Years
23%
|
CAGR 5-Years
16%
|
CAGR 10-Years
16%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Long-Term Investments
$133m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
CVS Health Corp
NYSE:CVS
|
Long-Term Investments
$24.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Cigna Corp
NYSE:CI
|
Long-Term Investments
$16B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-4%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Long-Term Investments
$17.7m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-15%
|
See Also
What is Amedisys Inc's Long-Term Investments?
Long-Term Investments
67m
USD
Based on the financial report for Mar 31, 2024, Amedisys Inc's Long-Term Investments amounts to 67m USD.
What is Amedisys Inc's Long-Term Investments growth rate?
Long-Term Investments CAGR 3Y
69%
Over the last year, the Long-Term Investments growth was 14%. The average annual Long-Term Investments growth rates for Amedisys Inc have been 69% over the past three years .